UBS Group AG - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 20 filers reported holding BELLEROPHON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,067
-65.6%
2,297
-10.7%
0.00%
Q1 2022$6,000
-14.3%
2,571
+15.8%
0.00%
Q4 2021$7,000
+75.0%
2,220
+89.6%
0.00%
Q3 2021$4,000
-75.0%
1,171
-65.2%
0.00%
Q2 2021$16,000
+45.5%
3,361
+59.8%
0.00%
Q1 2021$11,0000.0%2,103
+27.2%
0.00%
Q4 2020$11,000
-50.0%
1,653
-22.4%
0.00%
Q3 2020$22,000
+57.1%
2,130
+96.1%
0.00%
Q2 2020$14,000
+40.0%
1,086
+21.5%
0.00%
Q1 2020$10,0008940.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
PFS Partners, LLC 6,000$2,3860.00%
ACADIAN ASSET MANAGEMENT LLC 383,178$1520.00%
TWO SIGMA INVESTMENTS, LP 113,911$45,2910.00%
OSAIC HOLDINGS, INC. 557$2210.00%
US BANCORP \DE\ 1,221$4850.00%
WELLS FARGO & COMPANY/MN 180,066$71,5940.00%
NORTHERN TRUST CORP 30,251$12,0280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 2,100$8400.00%
GEODE CAPITAL MANAGEMENT, LLC 95,656$38,2620.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders